NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
CytoDyn, Inc.
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois